GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
CEBPG
|
ENSG00000153879.4 | CCAAT enhancer binding protein gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CEBPG | hg19_v2_chr19_+_33865218_33865254 | -0.20 | 3.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_5248294 | 23.09 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr3_+_186435137 | 16.49 |
ENST00000447445.1
|
KNG1
|
kininogen 1 |
chr3_+_186435065 | 14.49 |
ENST00000287611.2
ENST00000265023.4 |
KNG1
|
kininogen 1 |
chr4_+_74269956 | 12.80 |
ENST00000295897.4
ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB
|
albumin |
chr3_+_186330712 | 11.91 |
ENST00000411641.2
ENST00000273784.5 |
AHSG
|
alpha-2-HS-glycoprotein |
chr9_+_117085336 | 10.38 |
ENST00000259396.8
ENST00000538816.1 |
ORM1
|
orosomucoid 1 |
chr6_+_31895467 | 9.19 |
ENST00000556679.1
ENST00000456570.1 |
CFB
CFB
|
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr9_+_117092149 | 9.17 |
ENST00000431067.2
ENST00000412657.1 |
ORM2
|
orosomucoid 2 |
chr9_+_130911770 | 8.97 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
chr9_+_130911723 | 8.06 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
chr2_-_21266935 | 7.71 |
ENST00000233242.1
|
APOB
|
apolipoprotein B |
chr16_+_72088376 | 7.14 |
ENST00000570083.1
ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP
HPR
|
haptoglobin haptoglobin-related protein |
chr19_-_6720686 | 6.72 |
ENST00000245907.6
|
C3
|
complement component 3 |
chr17_-_64225508 | 6.44 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr6_+_31895480 | 6.04 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
C2
CFB
|
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr19_-_40971667 | 5.96 |
ENST00000263368.4
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr13_-_46679185 | 5.96 |
ENST00000439329.3
|
CPB2
|
carboxypeptidase B2 (plasma) |
chr8_-_6837602 | 5.93 |
ENST00000382692.2
|
DEFA1
|
defensin, alpha 1 |
chr13_-_46679144 | 5.87 |
ENST00000181383.4
|
CPB2
|
carboxypeptidase B2 (plasma) |
chr2_-_216300784 | 5.79 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr11_+_18287801 | 5.43 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
chr11_-_18270182 | 5.17 |
ENST00000528349.1
ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2
|
serum amyloid A2 |
chr12_-_12491608 | 5.12 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
chr11_+_18287721 | 5.01 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
chr6_+_31895254 | 4.85 |
ENST00000299367.5
ENST00000442278.2 |
C2
|
complement component 2 |
chr3_+_157154578 | 4.62 |
ENST00000295927.3
|
PTX3
|
pentraxin 3, long |
chr12_-_96390063 | 4.55 |
ENST00000541929.1
|
HAL
|
histidine ammonia-lyase |
chr11_-_18258342 | 4.54 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
chr7_+_22766766 | 4.42 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr1_-_153321301 | 4.37 |
ENST00000368739.3
|
PGLYRP4
|
peptidoglycan recognition protein 4 |
chr3_-_49726486 | 4.31 |
ENST00000449682.2
|
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr4_+_71248795 | 3.99 |
ENST00000304915.3
|
SMR3B
|
submaxillary gland androgen regulated protein 3B |
chrX_+_138612889 | 3.93 |
ENST00000218099.2
ENST00000394090.2 |
F9
|
coagulation factor IX |
chr2_-_112614424 | 3.92 |
ENST00000427997.1
|
ANAPC1
|
anaphase promoting complex subunit 1 |
chr1_+_111770232 | 3.63 |
ENST00000369744.2
|
CHI3L2
|
chitinase 3-like 2 |
chr1_+_111770278 | 3.55 |
ENST00000369748.4
|
CHI3L2
|
chitinase 3-like 2 |
chrX_+_46937745 | 3.54 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
chr6_-_135271260 | 3.54 |
ENST00000265605.2
|
ALDH8A1
|
aldehyde dehydrogenase 8 family, member A1 |
chr1_+_245133278 | 3.50 |
ENST00000366522.2
|
EFCAB2
|
EF-hand calcium binding domain 2 |
chr6_-_135271219 | 3.29 |
ENST00000367847.2
ENST00000367845.2 |
ALDH8A1
|
aldehyde dehydrogenase 8 family, member A1 |
chr3_-_194072019 | 3.22 |
ENST00000429275.1
ENST00000323830.3 |
CPN2
|
carboxypeptidase N, polypeptide 2 |
chr1_-_47655686 | 3.17 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr14_-_70263979 | 3.13 |
ENST00000216540.4
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1 |
chr1_-_161277210 | 3.13 |
ENST00000491222.2
|
MPZ
|
myelin protein zero |
chr8_-_121824374 | 3.06 |
ENST00000517992.1
|
SNTB1
|
syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) |
chr4_+_71226468 | 2.99 |
ENST00000226460.4
|
SMR3A
|
submaxillary gland androgen regulated protein 3A |
chr11_-_124806297 | 2.94 |
ENST00000298251.4
|
HEPACAM
|
hepatic and glial cell adhesion molecule |
chr8_-_6795823 | 2.92 |
ENST00000297435.2
|
DEFA4
|
defensin, alpha 4, corticostatin |
chr22_-_30901637 | 2.90 |
ENST00000381982.3
ENST00000255858.7 ENST00000540456.1 ENST00000392772.2 |
SEC14L4
|
SEC14-like 4 (S. cerevisiae) |
chr12_+_57522258 | 2.89 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr3_-_158390282 | 2.73 |
ENST00000264265.3
|
LXN
|
latexin |
chr12_-_96390108 | 2.73 |
ENST00000538703.1
ENST00000261208.3 |
HAL
|
histidine ammonia-lyase |
chr1_+_196743912 | 2.65 |
ENST00000367425.4
|
CFHR3
|
complement factor H-related 3 |
chr14_-_80677815 | 2.64 |
ENST00000557125.1
ENST00000555750.1 |
DIO2
|
deiodinase, iodothyronine, type II |
chr3_+_178253993 | 2.37 |
ENST00000420517.2
ENST00000452583.1 |
KCNMB2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
chr3_-_148939835 | 2.37 |
ENST00000264613.6
|
CP
|
ceruloplasmin (ferroxidase) |
chr12_-_114841703 | 2.32 |
ENST00000526441.1
|
TBX5
|
T-box 5 |
chr2_+_102721023 | 2.29 |
ENST00000409589.1
ENST00000409329.1 |
IL1R1
|
interleukin 1 receptor, type I |
chr5_+_49963239 | 2.22 |
ENST00000505554.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr11_+_59824060 | 2.17 |
ENST00000395032.2
ENST00000358152.2 |
MS4A3
|
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
chr1_+_196743943 | 2.16 |
ENST00000471440.2
ENST00000391985.3 |
CFHR3
|
complement factor H-related 3 |
chr14_+_96000930 | 1.95 |
ENST00000331334.4
|
GLRX5
|
glutaredoxin 5 |
chrX_-_135333722 | 1.94 |
ENST00000316077.9
|
MAP7D3
|
MAP7 domain containing 3 |
chr5_-_121413974 | 1.93 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chrX_+_49644470 | 1.87 |
ENST00000508866.2
|
USP27X
|
ubiquitin specific peptidase 27, X-linked |
chr11_+_59824127 | 1.84 |
ENST00000278865.3
|
MS4A3
|
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
chr4_+_175839506 | 1.82 |
ENST00000505141.1
ENST00000359240.3 ENST00000445694.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
chr5_-_146258205 | 1.61 |
ENST00000394413.3
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr6_-_133055815 | 1.60 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
chr17_-_39769005 | 1.58 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr9_+_115913222 | 1.57 |
ENST00000259392.3
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2 |
chr12_-_53074182 | 1.56 |
ENST00000252244.3
|
KRT1
|
keratin 1 |
chr5_+_36152179 | 1.52 |
ENST00000508514.1
ENST00000513151.1 ENST00000546211.1 |
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
chr11_-_33913708 | 1.51 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr4_+_175839551 | 1.50 |
ENST00000404450.4
ENST00000514159.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
chr4_-_119274121 | 1.47 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
chr19_+_55417499 | 1.47 |
ENST00000291890.4
ENST00000447255.1 ENST00000598576.1 ENST00000594765.1 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
chr12_-_71551868 | 1.35 |
ENST00000247829.3
|
TSPAN8
|
tetraspanin 8 |
chr19_+_55417530 | 1.33 |
ENST00000350790.5
ENST00000338835.5 ENST00000357397.5 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
chr9_+_136399929 | 1.32 |
ENST00000393060.1
|
ADAMTSL2
|
ADAMTS-like 2 |
chr4_-_10023095 | 1.31 |
ENST00000264784.3
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr5_+_49962772 | 1.29 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr8_+_42552533 | 1.22 |
ENST00000289957.2
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal) |
chr3_+_40498783 | 1.19 |
ENST00000338970.6
ENST00000396203.2 ENST00000416518.1 |
RPL14
|
ribosomal protein L14 |
chr21_-_37852359 | 1.16 |
ENST00000399137.1
ENST00000399135.1 |
CLDN14
|
claudin 14 |
chr8_+_97597148 | 1.15 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
chr14_+_21387508 | 1.15 |
ENST00000555624.1
|
RP11-84C10.2
|
RP11-84C10.2 |
chr13_-_36788718 | 1.09 |
ENST00000317764.6
ENST00000379881.3 |
SOHLH2
|
spermatogenesis and oogenesis specific basic helix-loop-helix 2 |
chr3_+_73110810 | 1.07 |
ENST00000533473.1
|
EBLN2
|
endogenous Bornavirus-like nucleoprotein 2 |
chr1_+_158901329 | 0.99 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr4_+_70796784 | 0.97 |
ENST00000246891.4
ENST00000444405.3 |
CSN1S1
|
casein alpha s1 |
chr1_+_172389821 | 0.96 |
ENST00000367727.4
|
C1orf105
|
chromosome 1 open reading frame 105 |
chr2_-_32390801 | 0.96 |
ENST00000608489.1
|
RP11-563N4.1
|
RP11-563N4.1 |
chr19_+_47538560 | 0.96 |
ENST00000439365.2
ENST00000594670.1 |
NPAS1
|
neuronal PAS domain protein 1 |
chr1_+_245133062 | 0.93 |
ENST00000366523.1
|
EFCAB2
|
EF-hand calcium binding domain 2 |
chr18_+_33767473 | 0.92 |
ENST00000261326.5
|
MOCOS
|
molybdenum cofactor sulfurase |
chr10_-_70092635 | 0.90 |
ENST00000309049.4
|
PBLD
|
phenazine biosynthesis-like protein domain containing |
chr10_-_92681033 | 0.88 |
ENST00000371697.3
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle) |
chr16_+_33020496 | 0.88 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
chr11_+_60048053 | 0.86 |
ENST00000337908.4
|
MS4A4A
|
membrane-spanning 4-domains, subfamily A, member 4A |
chr19_+_49258775 | 0.86 |
ENST00000593756.1
|
FGF21
|
fibroblast growth factor 21 |
chr15_-_34628951 | 0.81 |
ENST00000397707.2
ENST00000560611.1 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr21_+_38792602 | 0.75 |
ENST00000398960.2
ENST00000398956.2 |
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
chr6_-_27799305 | 0.69 |
ENST00000357549.2
|
HIST1H4K
|
histone cluster 1, H4k |
chr4_-_70826725 | 0.69 |
ENST00000353151.3
|
CSN2
|
casein beta |
chr6_-_133055896 | 0.66 |
ENST00000367927.5
ENST00000425515.2 ENST00000207771.3 ENST00000392393.3 ENST00000450865.2 ENST00000392394.2 |
VNN3
|
vanin 3 |
chr13_-_72441315 | 0.65 |
ENST00000305425.4
ENST00000313174.7 ENST00000354591.4 |
DACH1
|
dachshund homolog 1 (Drosophila) |
chr11_-_102668879 | 0.64 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr21_+_43619796 | 0.63 |
ENST00000398457.2
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr2_-_89310012 | 0.63 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr1_+_154377669 | 0.61 |
ENST00000368485.3
ENST00000344086.4 |
IL6R
|
interleukin 6 receptor |
chr19_+_2476116 | 0.60 |
ENST00000215631.4
ENST00000587345.1 |
GADD45B
|
growth arrest and DNA-damage-inducible, beta |
chr20_-_48782639 | 0.58 |
ENST00000435301.2
|
RP11-112L6.3
|
RP11-112L6.3 |
chr1_-_179112189 | 0.57 |
ENST00000512653.1
ENST00000344730.3 |
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr7_-_83824169 | 0.56 |
ENST00000265362.4
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr12_-_323689 | 0.56 |
ENST00000428720.1
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr11_+_60048129 | 0.56 |
ENST00000355131.3
|
MS4A4A
|
membrane-spanning 4-domains, subfamily A, member 4A |
chr19_+_49259325 | 0.54 |
ENST00000222157.3
|
FGF21
|
fibroblast growth factor 21 |
chr14_-_80677970 | 0.53 |
ENST00000438257.4
|
DIO2
|
deiodinase, iodothyronine, type II |
chr11_-_72504637 | 0.52 |
ENST00000536377.1
ENST00000359373.5 |
STARD10
ARAP1
|
StAR-related lipid transfer (START) domain containing 10 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr19_+_6887571 | 0.51 |
ENST00000250572.8
ENST00000381407.5 ENST00000312053.4 ENST00000450315.3 ENST00000381404.4 |
EMR1
|
egf-like module containing, mucin-like, hormone receptor-like 1 |
chr12_-_57522813 | 0.51 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr17_-_3182268 | 0.48 |
ENST00000408891.2
|
OR3A2
|
olfactory receptor, family 3, subfamily A, member 2 |
chr7_-_8276508 | 0.39 |
ENST00000401396.1
ENST00000317367.5 |
ICA1
|
islet cell autoantigen 1, 69kDa |
chr12_-_8693539 | 0.35 |
ENST00000299663.3
|
CLEC4E
|
C-type lectin domain family 4, member E |
chr22_-_30867973 | 0.34 |
ENST00000402286.1
ENST00000401751.1 ENST00000539629.1 ENST00000403066.1 ENST00000215812.4 |
SEC14L3
|
SEC14-like 3 (S. cerevisiae) |
chr20_+_54987168 | 0.31 |
ENST00000360314.3
|
CASS4
|
Cas scaffolding protein family member 4 |
chr12_-_71551652 | 0.30 |
ENST00000546561.1
|
TSPAN8
|
tetraspanin 8 |
chr20_+_361261 | 0.29 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
chr17_-_42200958 | 0.24 |
ENST00000336057.5
|
HDAC5
|
histone deacetylase 5 |
chr20_+_54987305 | 0.22 |
ENST00000371336.3
ENST00000434344.1 |
CASS4
|
Cas scaffolding protein family member 4 |
chr6_-_30710265 | 0.20 |
ENST00000438162.1
ENST00000454845.1 |
FLOT1
|
flotillin 1 |
chr14_+_21387491 | 0.14 |
ENST00000258817.2
|
RP11-84C10.2
|
RP11-84C10.2 |
chr4_+_71600144 | 0.13 |
ENST00000502653.1
|
RUFY3
|
RUN and FYVE domain containing 3 |
chr6_-_132939317 | 0.11 |
ENST00000275191.2
|
TAAR2
|
trace amine associated receptor 2 |
chr5_-_135701164 | 0.09 |
ENST00000355180.3
ENST00000426057.2 ENST00000513104.1 |
TRPC7
|
transient receptor potential cation channel, subfamily C, member 7 |
chr1_-_179112173 | 0.07 |
ENST00000408940.3
ENST00000504405.1 |
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 23.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
4.3 | 12.8 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
3.4 | 17.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
3.0 | 11.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.4 | 19.6 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.4 | 7.3 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
2.4 | 7.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
2.2 | 6.7 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
2.0 | 5.9 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
1.9 | 5.8 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.8 | 41.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.7 | 5.0 | GO:0002384 | hepatic immune response(GO:0002384) |
1.5 | 4.4 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
1.2 | 3.5 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
1.1 | 7.7 | GO:0006642 | triglyceride mobilization(GO:0006642) response to selenium ion(GO:0010269) |
1.0 | 10.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.0 | 2.9 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.9 | 4.6 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.8 | 2.3 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.8 | 2.3 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.7 | 7.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.6 | 6.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.5 | 11.9 | GO:0030502 | pinocytosis(GO:0006907) negative regulation of bone mineralization(GO:0030502) |
0.4 | 9.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 6.0 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 1.4 | GO:1904640 | response to methionine(GO:1904640) |
0.3 | 2.9 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.3 | 20.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 4.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 3.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.7 | GO:1903487 | regulation of lactation(GO:1903487) |
0.2 | 0.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 2.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 0.6 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
0.2 | 2.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 1.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 1.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 1.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.8 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.2 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 2.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 2.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 2.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 3.1 | GO:0098743 | cell aggregation(GO:0098743) |
0.1 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.6 | GO:0048880 | sensory system development(GO:0048880) |
0.1 | 1.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 3.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 2.8 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 3.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 1.9 | GO:0071108 | protein K63-linked deubiquitination(GO:0070536) protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 0.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 1.0 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.8 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 1.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 1.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 1.9 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 2.7 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 1.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 1.1 | GO:0048477 | oogenesis(GO:0048477) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 30.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.3 | 5.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.0 | 7.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.7 | 26.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 81.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 15.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 33.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 3.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 2.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 3.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 11.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 5.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 3.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 2.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 36.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 6.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 2.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 2.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.6 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 2.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 2.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.2 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 30.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.9 | 7.7 | GO:0035473 | lipase binding(GO:0035473) |
1.8 | 7.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.5 | 6.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
1.5 | 4.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
1.3 | 6.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 12.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 3.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 2.9 | GO:0042954 | apolipoprotein receptor activity(GO:0030226) lipoprotein transporter activity(GO:0042954) |
0.7 | 7.2 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.6 | 4.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.6 | 2.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.6 | 6.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 15.2 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 5.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 3.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 15.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 40.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 2.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 20.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 2.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 0.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.2 | 2.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.9 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 1.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 21.4 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 3.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 2.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 2.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 20.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 4.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.5 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 1.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 2.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 2.8 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 1.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.6 | GO:0003823 | antigen binding(GO:0003823) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 37.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 15.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 10.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 19.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 5.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 12.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 11.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 4.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 14.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 2.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 34.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.3 | 26.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.0 | 15.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 6.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.4 | 7.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 10.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 4.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 5.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 4.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 6.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 3.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 23.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 3.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 2.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 1.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |